The antibody is directed against a neoepitope formed by poly (C9) in the terminal complement complex (TCC). It reacts both with the membrane-bound C5b-9(m) and the fluid-phase (SC5b-9) complexes.
Бренд: Agilent Technologies
The antibody is directed against a neoepitope formed by poly (C9) in the terminal complement complex (TCC). It reacts both with the membrane-bound C5b-9(m) and the fluid-phase (SC5b-9) complexes.